Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen

This article has been updated

Abstract

Human microsomal cytochrome P450 2A6 (CYP2A6) contributes extensively to nicotine detoxication but also activates tobacco-specific procarcinogens to mutagenic products. The CYP2A6 structure shows a compact, hydrophobic active site with one hydrogen bond donor, Asn297, that orients coumarin for regioselective oxidation. The inhibitor methoxsalen effectively fills the active site cavity without substantially perturbing the structure. The structure should aid the design of inhibitors to reduce smoking and tobacco-related cancers.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Comparison of coumarin and methoxsalen binding to CYP2A6.

Similar content being viewed by others

Accession codes

Accessions

Protein Data Bank

Change history

  • 14 August 2005

    Sentence changed

Notes

  1. Note: In the version of this article initially published online, a sentence in the fifth paragraph of the article was incorrectly transcribed. The sentence originally read, “The furan oxygen is positioned closer to the nearest carbon than to the heme iron, and the inhibitor is not positioned well for aromatic hydroxylation or epoxidation.” The error has been corrected for the HTML and the print versions of the article.

References

  1. Malaiyandi, V., Sellers, E.M. & Tyndale, R.F. Clin. Pharmacol. Ther. 77, 145–158 (2005).

    Article  CAS  Google Scholar 

  2. Sellers, E.M., Kaplan, H.L. & Tyndale, R.F. Clin. Pharmacol. Ther. 68, 35–43 (2000).

    Article  CAS  Google Scholar 

  3. Sellers, E.M., Ramamoorthy, Y., Zeman, M.V., Djordjevic, M.V. & Tyndale, R.F. Nicotine Tob. Res. 5, 891–899 (2003).

    Article  CAS  Google Scholar 

  4. Patten, C.J. et al. Carcinogenesis 18, 1623–1630 (1997).

    Article  CAS  Google Scholar 

  5. Fujita, K. & Kamataki, T. Environ. Mol. Mutagen. 38, 339–346 (2001).

    Article  CAS  Google Scholar 

  6. Guengerich, F.P. in Cytochrome P450: Structure, Mechanism, and Biochemistry (ed. Ortiz de Montellano, P.R.) 377–530 (Kluwer Academic/Plenum Publishers, New York, 2005).

    Book  Google Scholar 

  7. Johnson, E.F. Drug Metab. Dispos. 31, 1532–1540 (2003).

    Article  CAS  Google Scholar 

  8. Burley, S.K. & Petsko, G.A. Science 229, 23–28 (1985).

    Article  CAS  Google Scholar 

  9. de Visser, S.P. & Shaik, S. J. Am. Chem. Soc. 125, 7413–7424 (2003).

    Article  CAS  Google Scholar 

  10. Yun, C.H., Kim, K.H., Calcutt, M.W. & Guengerich, F.P. J. Biol. Chem. 280, 12279–12291 (2005).

    Article  CAS  Google Scholar 

  11. Koenigs, L.L. & Trager, W.F. Biochemistry 37, 10047–10061 (1998).

    Article  CAS  Google Scholar 

  12. Kleywegt, G.J. & Jones, T.A. Acta Crystallogr. D 50, 178–185 (1994).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the US National Institutes of Health grant GM031001 (to E.F.J.) and fellowship 12FT-0185 from the Tobacco-Related Disease Research Program (to J.K.Y.). Facilities for computer-assisted sequence analysis, DNA sequencing and the synthesis of oligonucleotides were supported in part by the General Clinical Research Center grant M01 RR00833 and by the Sam and Rose Stein Charitable Trust. Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory (SSRL), a national user facility operated by Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research and by the US National Institutes of Health, National Center for Research Resources, Biomedical Technology Program and National Institute of General Medical Sciences. The authors thank F. Gonzalez (National Cancer Institute) for kindly providing the CYP2A6 cDNA.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to C David Stout or Eric F Johnson.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Fig. 1

The overall fold of CYP2A6 and comparison with CYP2C8. (PDF 170 kb)

Supplementary Fig. 2

Residue interactions that contribute to a compact polypeptide fold. (PDF 123 kb)

Supplementary Fig. 3

Wall-eyed stereo view of the potential hydrogen bonding of Asn297. (PDF 41 kb)

Supplementary Table 1

Data collection and refinement statistics. (PDF 28 kb)

Supplementary Methods (PDF 92 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yano, J., Hsu, MH., Griffin, K. et al. Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen. Nat Struct Mol Biol 12, 822–823 (2005). https://doi.org/10.1038/nsmb971

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nsmb971

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing